(Reuters) - British asset manager Woodford Investment Management Ltd disclosed a less than 5% stake in Circassia Pharmaceuticals Plc CIRCI.L as of Sept. 13, a filing showed on Monday.
Woodford earlier held a 19.95% stake in the specialty biopharmaceutical company, according to the filing.
Woodford Patient Capital Trust WPCT.L, whose portfolio manager is Woodford Investment Management Ltd, has been under pressure from lawmakers and investors for not being able to meet redemption requests, after the flagship equity income fund was frozen in June.
Reporting by Samantha Machado in Bengaluru; Editing by Shailesh Kuber
Our Standards: The Thomson Reuters Trust Principles.